NCT04294160 2025-12-24A Study of Select Drug Combinations in Adult Patients With Advanced/Metastatic BRAF V600 Colorectal CancerNovartisPhase 1 Terminated122 enrolled
NCT04892017 2025-10-10A Phase 1/2 Study of Inlexisertib (DCC-3116) in Patients With RAS/MAPK Pathway Mutant Solid TumorsDeciphera Pharmaceuticals, LLCPhase 1/2 Active not recruiting144 enrolled
NCT05071183 2024-04-02A Study of Repotrectinib in Combination With Other Anticancer Therapies for the Treatment of Subjects With KRAS-Mutant Solid TumorsTurning Point Therapeutics, Inc.Phase 1/2 Terminated9 enrolled 17 charts
NCT02027961 2019-05-17Phase 1 Safety and Tolerability of MEDI4736 in Combination With Dabrafenib and Trametinib or With Trametinib AloneMedImmune LLCPhase 1 Completed68 enrolled